Venous Thrombosis in Women

Pregnancy, the Contraceptive Pill and Hormone Replacement Therapy

Ian A. Greer

• Publisher: CRC Press
• Year: 2003
• ISBN:
  9781135401399
• Edition: 1
• Topic: Medicina
• Subtopic: Teoría, práctica y referencia médicas

The impact of hormones on deep venous thrombosis is one of the most charged and debated subjects in contraceptive medicine. Female hormonal balance is primarily affected by the use of either oral contraceptives or HRT. For a long time it has been recognized that oral contraceptives can raise the incidence of DVT; however, there has been an enormous controversy as to whether all progestins do this equally or whether some have a greater impact than others where oral contraception is concerned. Written by a world leader on the subject, this book offers the latest clinical information about the effects of pregnancy, the contraceptive pill, and hormone replacement therapy on thrombotic problems in women.

References

1. Ruggerri ZM, Dent JA, Saldivar E, etal.Contribution of distinct adhesion interactions to platelet aggregation in flowing blood. Blood 1999;94:172–8 flowing blood. Blood 1999;94:172–8

2. Tracy PB. Role of platelets and leukocytes and coagulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis andThrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:575–96

3. Morrissey JH. Tissue factor and factor VII initiation of coagulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:89–102

4. Colman RW, Clowes AW, George JN, et al. Overview of coagulation fibrinolysis and their regulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. BasicPrinciples and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:3–16

5. Bachman F. Plasminogen-plasmin enzyme system. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis andThrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:275–320

6. Stiko A, Hervio L, Loskautoff D. Plasminogen activator inhibitors. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:355–66

7. Robbie LA, Bennett B, Keyt BA, et al. Effective lysis of model thrombi by a t-PA mutant (A-473S) that is resistant to ɑ2- antiplasmin. Br JHaematol 2000; 111:517–23 antiplasmin. Br JHaematol 2000; 111:517–23

8. Stirling Y, Woolf L, North WRS, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176–82

9. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I Normal condition. Gynaecol Obstet Invest 1981;12:141–54

10. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1983;61:238–40

11. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988;319:142–5

12. Cadroy Y, Grandjean H, Pichon J, etal.Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993;100:416–20

13. Tygart SG, McRoyan DK, Spinnato JA, et al. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 1986;154:883–7

14. Singer CRJ, Walker JJ, Cameron A, et al. Platelet studies in normal pregnancy and pregnancy induced hypertension. Clin Lab Haematol 1986;8:27–32

15. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 1994;24:217–19

16. Morrison R, Crawford J, MacPherson M, et al. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemostas 1985;54:607–11 hypertension. Thromb Haemostas 1985;54:607–11

17. Burgess-Wilson ME, Morrison R, Heptinstall S. Spontaneous platelet aggregation in heparinised blood during pregnancy. Thromb Res 1986;37:385–93 during pregnancy. Thromb Res 1986;37:385–93

18. Louden KA, Broughton-Pipkin F, Heptinstall S, et al. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium. Br J Obstet Gynaecol 1990;97:1108–14

19. Norris LA, Sheppard BL, Bonnar J. Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dezmegrel. Br J Obstet Gynaecol 1992; 99:253–7 20. Horn EH, Hardy E, Cooper J, et al. Platelet reactivity in vitro

20. Horn EH, Hardy E, Cooper J, et al. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Thromb Haemostas 1996;75:346–51

21. Horn EH, Cooper JA, Hardy E, et al.Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. Clin Sci 1995;89:91–5

22. O’Brien WF, Saba HI, Knuppel RA, et al. Alterations in platelet concentration and aggregation in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol 1986;155:486–9

23. Douglas JT, Shah M, Lowe GDO, etal.Plasma fibrinopeptide A and ß-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 1982;47:54–5

24. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79: 1166–70

25. Persson BL, Stenberg P, Holmberg L, et al. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation. J Dev Physiol 1980;2:37–41 retardation. J Dev Physiol 1980;2:37–41

26. Halligan A, Bonnar J, Sheppard B, et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br JObstet Gynaecol 1994;101:488–92

27. Eichinger S, Weltermann A, Philipp K, et al. Prospective evaluation of haemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999;82:1232–6

28. Holmes VA, Wallace JMW, Gilmore WS, et al. Tisssue factor expression on monocyte subpopulations during normal pregnancy. ThrombHaemost 2002;87:953–8

29. Comp PC, Thurneau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986;68:881–5

30. Bonnar J, McNicol GP, Douglas AS, et al. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J1970;2:200–3

31. Booth N, Reith A, Bennett B, et al. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy. ThrombHaemost 1988;59:77–9

32. Lecander I, Astedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986;62:221–8

33. Nil...

Table of contents

• Cover Page
• Title Page
• Copyright Page
• I: Overview of the hemostatic and fibrinolytic systems
• 2: Physiological changes inhemostasis and fibrinolysis in pregnancy
• 3: Venous thromboembolism in pregnancy
• 4: Venous thromboembolism and the oral contraceptive pill
• 5: Venous thromboembolism andhormone replacement therapy
• References